Global Particle Therapy Market Introduction:
“The global Particle Therapy market size is expected to be worth around US$ 234.5 million by 2021 from US$ 141.2 million in 2031, growing at a CAGR of 5.19% during the forecast period 2021 to 2031.”
The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global particle therapy market report has been segmented on the basis of therapy type, component type, system, cancer type, application, and region.
Particle therapy is an external beam radiation therapy that uses high-energy protons, neutrons, or positive ion for cancer treatment. The method of particle therapy is to target tumors by high energy ionized particles. These particles damage the DNA of target tissue cells and eventually cause them to death, thus the cancer cells are particularly vulnerable to attack due to reduced ability to repair damaged DNA.
Increasing adoption of particle therapy, owing to its advantages such as high degree of precision, shorter duration of treatment, and lower side-effects as compared to conventional photon therapies using X-rays, is a key factor expected to drive growth of the global particle therapy market over the forecast period. In addition, increasing investment for cancer research, is another factor anticipated to fuel growth of the target market over the forecast the period.
Moreover, increasing number of particle therapy centers and clinical trials, is a dynamic factor expected to propel growth of the target market over the forecast period.
However, non-favorable reimbursement policies and limited insurance coverage for particle therapy is a major factor expected to restrain growth of the target market over the forecast period. In addition, infrastructural challenges in healthcare facilities and accessibility of treatments are other factors expected to hamper growth of the target market during the forecast period.
Growing adoption of particle therapy in developing countries, is a factor expected to create a lucrative opportunity for driving growth of the global particle therapy market over the forecast period. Increasing adoption of pencil-beam scanning, is an ongoing trend which support to drive growth of the target market over the forecast period.
Analysis by Segment:
On the basis of therapy type, the proton therapy segment is expected to hold major revenue share in the global particle therapy market during the forecast period. On the basis of product & service, the synchrotrons segment is anticipated to witness highest growth rate in the target market over the forecast period.
This can be attributed to the growing adoption of the therapy in research activities and increasing investments for the development of the facilities. On the basis of application, the treatment application segment is estimated to account for highest revenue share in the target market during the forecast period.
Analysis by Region:
The North America particle therapy market accounted major revenue share in the target market and is expected to maintain its dominance over the forecast period. The particle therapy market in Europe is anticipated to contribute significant revenue share in the global particle therapy market in the next coming years.
The Asia Pacific market is estimated to register for significant growth in terms of value in the target market during the forecast period owing to increasing per capita income, improving healthcare infrastructure, and supportive government activities in countries such as China, Japan, and India in the region.
Market Segmentation and Key Players Operating in The Global Particle Therapy Market:
Segmentation on The Basis of Therapy Type:
- Proton Therapy
- Heavy Ion Therapy
- Fast-neutron Therapy
Segmentation on the Basis of Component Type:
Segmentation on the Basis of System:
- Multi-room Systems
- Single-room Systems
Segmentation on the Basis of Cancer Type:
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Head and Neck Cancer
- Other Cancers (Lymphoma, Spine Cancer, Pancreatic Cancer, Brain Cancer, Skin Cancer, etc.)
Segmentation on the Basis of Application:
- Treatment Application
- Research Application
Segmentation on the Basis of Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Varian Medical Systems, Inc.
- Ion Beam Applications SA (IBA)
- Mevion Medical Systems, Inc.
- Provision Healthcare, LLC
- Sumitomo Heavy Industries, Ltd.
- Hitachi, Ltd.
- Optivus Proton Therapy, Inc.
- ProTom International, Inc.
- Advanced Oncotherapy plc
- Danfysik A/S
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!